Sumita Ray
Chief Compliance Officer, Pharmacyclics.
Companies
- Cue Biopharma, Inc.General counsel Jun 11, 2026 to now1
- Biomea Fusion, Inc.Board member Jun 21, 2021 to now2
- Vaxxinity, Inc.General counsel Oct 11, 2023 to Apr 29, 20243
- Instil Bio, Inc.General counsel May 3, 2022 to Jan 20, 20234
- Calithera Biosciences, Inc.Officer Oct 3, 2017 to Jan 27, 20225
- PharmacyclicsChief Compliance Officer Jun 24, 2013 to Nov 6, 20136
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Cue Biopharma, Inc. CUE118,545 shares7$2.0M at $16.71Aug 13, 2026
- Calithera Biosciences, Inc.105,000 shares8Nov 5, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 13, 2026Sold 4 shares at $31.13 of Cue Biopharma, Inc.7
- Aug 13, 2026Sold 6,442 shares at $30.35 of Cue Biopharma, Inc.7
- Aug 13, 2026Sold 2,383 shares at $29.37 of Cue Biopharma, Inc.7
- Aug 13, 2026Exercised options 18,196 shares of Cue Biopharma, Inc.7
- Jul 9, 2026Granted 54,589 shares of Cue Biopharma, Inc.9
- Nov 5, 2021Granted 12,000 shares of Calithera Biosciences, Inc.8
- Oct 27, 2021Granted 36,000 shares of Calithera Biosciences, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCue Biopharma, Inc., General counsel
- 2SEC EDGARBiomea Fusion, Inc., Board member
- 3SEC EDGARVaxxinity, Inc., General counsel
- 4SEC EDGARInstil Bio, Inc., General counsel
- 5SEC EDGARCalithera Biosciences, Inc., Officer
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Jul 10, 2026
- 10SEC EDGARForm 4 filed Oct 29, 2021